Neoadjuvant Therapy and Lymphadenectomy in Esophageal Cancer: Both Are Essential to Maximize Survival Benefit. [electronic resource]
Producer: 20171218Description: e41-e42 p. digitalISSN:- 1528-1140
No physical items for this record
Publication Type: Letter; Comment
There are no comments on this title.
Log in to your account to post a comment.